To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Dexamethasone Reduces Postoperative Pain, Opioid and Antiemetic Use in Total Shoulder Arthroplasty

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
August 2021

Dexamethasone Reduces Postoperative Pain, Opioid and Antiemetic Use in Total Shoulder Arthroplasty

Vol: 77| Issue: 1| Number:1| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Dexamethasone decreases postoperative opioid and antiemetic use in shoulder arthroplasty patients: a prospective, randomized controlled trial.

J Shoulder Elbow Surg. 2021 Jul;30(7): 1544-1552.

Contributing Authors:
EA Klag NA Kuhlmann JS Tramer S Franovic SJ Muh

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Seventy five patients undergoing anatomic or reverse total shoulder arthroplasty (TSA) were randomized to receive perioperative intravenous dexamethasone (n=43) or no treatment (n=32). The primary outcome of interest was postoperative morphine use over the first 24h postoperatively. Other outcomes of interest included postoperative pain scores, antiemetic use, nausea and vomiting, length of stay a...

Join the Conversation

Please Login or Join to leave comments.